The British Pharmaceutical Conference & Exhibition 2007


Programme
PROGRAMME LINKS Monday - Tuesday - Wednesday	am Tuesday 11 September

10.00 – 10.45 COFFEE, TEA, EXHIBITION, BPC-PJ CAREERS FORUM AND POSTERS

The science of pharmacy	Science into practice	The practice of pharmacy

8.00 – 8.45 Academy of Pharmaceutical Sciences Annual General Meeting Breakfast will be provided courtesy of Pfizer
		9.15 – 10.00 Keynote address The community pharmacy contract: reflections from the national evaluation
	10.45 – 12.45 Balancing risk and regulation: the increasing role of patients and pharmacists	In the chair: Professor Theo Raynor, Practice Chairman, BPC 2007 Professor Alison Blenkinsopp, Keele University
10.45 – 12.45 A choice of:	In the chair: Dr June Raine, Medicines and Healthcare products Regulatory Agency	10.45 – 12.45 A choice of:
Nanotechnology in drug delivery and medicine	Finding the balance	Getting the right balance for OTC medicines
In association with the United Kingdom-Ireland Controlled Release Society	Dr June Raine, Medicines and Healthcare products Regulatory Agency	In association with the Company Chemists’ Association
In the chair: Dr Karl Malcom, Queen’s University Belfast and Dr Woei Ping Cheng, The Robert Gordon University, Aberdeen	Patient reporting, Yellow Cards, and the role of the pharmacist	In the chair: Steve Churton, Company Chemists’ Association
	Dr Keith Beard, Victoria Infirmary, Glasgow	How to improve safety of OTC medicines
Nanoparticles as subunit vaccine delivery systems	What do the public know about drug regulation?	Professor Christine Bond, University of Aberdeen
Professor Thomas Rades, National School of Pharmacy, New Zealand	Simon Gregor, Medicines and Healthcare products Regulatory Agency	Maximising pharmacy input for best OTC outcomes
Fabrication of nano-sized self-assemblies composed of novel amphiphilic graft polymers for protein and drug delivery	Lessons from Isotretinoin Alison Bowser, Acne Support Group	Dr Terry Maguire, Maguire’s Pharmacy, Belfast
		New OTC indications: who is telling people about the benefits?
Dr Woei Ping Cheng, The Robert Gordon University, Aberdeen		Helen Darracott, Proprietary Association of Great Britain
Inhalation nanotoxicology and how it may impact on drug delivery to the lung		Or
Dr Lea Ann Dailey, King’s College London		Thinking outside of the box- communicating risks and benefits to people in special groups
Screening of pharmaceutical materials through nanoscale measurements		In the chair: Peter White, Broadcaster
		Communicating with visually impaired people
Professor Clive Roberts, University of Nottingham		Peter White, Broadcaster
		Hearing difficulties
Or		Sue Davies, Royal National Institute for the Deaf
Herbal medicinal products		People for whom English is not a first language
In association with Joint Pharmaceutical Analysis Group		Professor Helen Hally, Race for Health
In the chair: Professor Tony Moffat, University of London		Learning difficulties Linda Chadburn, Calderstones NHS Trust
What should be identified and measured?
Dr Keith Helliwell, William Ransom & Son		Or
A regulatory perspective
Dr Linda Anderson, Medicines and Healthcare products Regulatory Agency		From prescribing to plastic surgery in community pharmacy: opportunity and risk in a permissive age
Development of BP monographs for herbal medicines		In association with the National Pharmacy Association
Stephen Young, Medicines and Healthcare products Regulatory Agency		Sponsored by
Cannabis as a medicine		In the chair: Dilip Joshi, National Pharmacy Association Beth Taylor, NHS Primary Care Contracting Tim Jones, Commissioning Consultant Ian Facer, Community Pharmacist Alison Strath, Scottish Executive Trish O’Gorman, Improvement Foundation Dr Tracey Thornley, Boots The Chemists Dr David Colin Thomé, Department of Health
Dr Brian Whittle, GW Pharma Ltd

Or
Inhalation and drug delivery
In association with the Academy of Pharmaceutical Sciences
In the chair: Dr Peter Seville, Aston University and Dr Rob Price, University of Bath		Or
The right excipients for inhaled products: balancing formulation and regulatory requirements		Prevention and management of chronic disease Selected papers in pharmacy practice research
Dr Sebastian Kaerger, Novartis		In the chair: Professor Carmel Hughes, Queen's University Belfast and Professor Rachel Elliott, University of Nottingham
Controlled release formulations for pulmonary drug delivery
Dr Peter Seville, Aston University
Can respiratory epithelial cell lines tell us what is particularly important?
Dr Ben Forbes, King’s College London
Understanding the impact of dry powder formulation characteristics for preclinical models
Dr Jane Burrows, Pfizer

Or
Risks and benefits: drug evaluation in the 21st Century
In association with the British Pharmacological Society
In the chair: Professor Walker
Mass screen versus intelligent selection
Emeritus Professor Michael Walker, University of British Columbia and Verona Pharma plc, Canada
Preclinical evaluation
Professor Brian Furman, University of Strathclyde
Early clinical experience: learning from Northwick Park
Dr Tim Mant, Quintiles UK Ltd
1984: was it better then?
Professor Trevor M. Jones, King’s College London

12.45 – 14.00 LUNCH, EXHIBITION, BPC-PJ CAREERS FORUM AND POSTERS 13.20 – 14.00 BPC-PJ ROUND TABLE DISCUSSION. In the chair: Olivia Timbs, The Pharmaceutical Journal
	pm Tuesday 11 September
14.45 – 15.15 COFFEE, TEA, EXHIBITION, BPC-PJ CAREERS FORUM AND POSTERS
The science of pharmacy	Science into practice	The practice of pharmacy


14.00 – 14.45 Keynote address Cox-2 inhibitors: blood, guts, fashion and politics		14.00 – 14.45 Keynote address "I’ve run out of the white ones"
In the chair: Professor Clive Wilson, Science Chairman, BPC 2007		In the chair: Professor Theo Raynor, Practice Chairman, BPC 2007
Professor Chris Hawkey, University of Nottingham	15.15 – 17.15 Regulation and balance: cost benefit analysis	Gill Dorer, Patient Consultant
	15.15 – 17.15 Regulation and balance: cost benefit analysis
15.15 – 17.15 A choice of:	In the chair: Peter White, Broadcaster	15.15 – 17.15 A choice of:
Nanotechnology in drug delivery and medicine	Understanding the balance: the health economics	Always read the leaflet: improving the readability of patient information leaflets
In association with the United Kingdom-Ireland Controlled Release Society	Professor Rachel Elliott, University of Nottingham	In the chair: Jan MacDonald, Medicines and Healthcare products Regulatory Agency
In the chair: Professor Jayne Lawrence, Royal Pharmaceutical Society of Great Britain and King’s College London and Dr Yvonne Perrie, Aston University	The NICE appraisal process	Promoting Excellence in Consumer Medicines Information – from PECMI to the present
	Dr Carole Longson, NICE	Jan MacDonald, Medicines and Healthcare products Regulatory Agency
EPR-effect, and its mechanism, and further extension towards more tumor selective cancer therapy	Making the decisions balancing the risks
	Making the decisions balancing the risks	Here are the headlines – Better risk communication in patient information leaflets
Journal of Drug Targeting Award Speaker	Tim Riley, Tameside and Glossop PCT	Dr Rafe Suvarna, Medicines and Healthcare products Regulation Agency
Professor Hiroshi Maeda, Sojo University, Japan		The next steps for patient leaflets
Endocytic pathways: gateways for intracellular drug delivery	Influencing and living with the decisions : a patient view	Madeleine Wang, Patient advocate
Dr Arwyn Tomos Jones, Welsh School of Pharmacy	Pamela Dix, Disaster Action
Design, synthesis and characterisation of biorecognisable biomedical polymers for drug delivery		Or
Professor Jindrich (Henry) Kopecek, University of Utah, USA		The risks and benefits of self-administration of medicines in hospital
Delivery of poorly water soluble drug using NanoCrystal® technology: clinical challenges, commercial opportunities		In association with the Hospital Pharmacists Group In the chair: Professor Ray Fitzpatrick, Hospital Pharmacists Group
Dr Leonard O’Mahony, Elan Pharmaceuticals Ltd		Self-administration: a patient’s perspective
		Bill Davidson, Patient consultant
Or		Pushing back the frontiers in self-administration: issues in mental health
Short papers in pharmaceutical analysis For further information, click here		Salwa Morcos, Kent and Medway NHS and Social Care Partnership Trust
In association with the Joint Pharmaceutical Analysis Group		Issues on paediatric wards
In the chair: Dr Steve Robinson, Pfizer		William Thornhill, Guy’s and St Thomas’ Hospital NHS Trust
		Self-administration of Methotrexate in the outpatient setting
Or		Jenny Morrey, Dudley Group of Hospitals NHS Trust
New scientists: recent advances in pharmaceutical science For further information, click here		A debate: This House believes that it is entirely appropriate for self-administration of medicines to be an indicator in Medicines Management Scores as part of the Trust annual health check For the motion: Sue Ashwell, Cambridgeshire PCT
In association with the Academy of Pharmaceutical Sciences
In the chair: Dr Rachel Bridson, University of Birmingham and Dr Claire Thompson, GlaxoSmithKline
		Against the motion: Ann Jacklin, Hammersmith Hospital
Or
Quality by design; mitigating risk in drug development		Or
In the chair: Dr Claire Madden-Smith from Molecular Profiles and Professor Ron Roberts, AstraZeneca
The use of PAT in drug development processes		The new contract in England and Wales: is it achieving its aims?
Dr Ken Morris, Purdue University, USA		Selected papers in pharmacy practice research
Materials science and quality by design at the drug product/drug substance interface		In the chair: Dr Phillip Rogers, University of Bath and Dr Mary Tully, University of Manchester
Dr Robert Docherty, Pfizer
Using QbD in a drug product arena		Or
Ryan Gibb, AstraZeneca
Regulatory aspects of QbD		Hot topic
Dr Ajaz Hussain, Sandoz		This session will cover current issues of the national Pharmacy Boards in England, Scotland and Wales.

17.15 – 18.15		17.15 – 18.15
Attended poster session incorporating wine reception and poster prize presentation		Attended practice poster session incorporating wine reception
Sponsored by		Sponsored by
		Poster prize presentation supported by International Journal of Pharmacy Practice

		17.45 – 18.45 Wine reception Sponsored by

		18.45 – 19.45
		Hot topic Supervision and responsible pharmacist
		Skill Mix: The responsible pharmacist Speakers to include Jeannette Howe, Department of Health

19.30 ACADEMY OF PHARMACEUTICAL SCIENCES BANQUET 20.30 DINNER AND DRINKS AVAILABLE AT THE BELUGA BAR

Top of Page ↑

PROGRAMME LINKS Monday - Tuesday - Wednesday
home - theme - highlights - programme - social events - call for papers - booking - press releases - awards